Wegovy works by mimicking a natural hormone in your body that helps regulate appetite and blood sugar, which can support reduced food intake and healthier eating patterns when combined with lifestyle changes
Semaglutide and tirzepatide for obesity: Effectiveness and valuedraft evidence report
Stephen O'Rahilly - beneficios riesgos GLP1 EN Stephen O'Rahilly Professor of Clinical Biochemistry and Medicine and Director of the Wellcome-MRC Institute of Metabolic Science-Metabolic Research Laboratories, University of Cambridge Studies such as these have to be interpreted very cautiously as the people studied have not been randomly allocated to GLP1 receptor agonist treatment, so any difference between those taking and not taking the class of drug could potentially be attributable to factors other than the drug
Published February 5, 2024
People taking semaglutide have, on average, lost up to 15% of their body weight
But even with deep discounts and renewed excitement around the year-end shopping season, doctors say its important to know where you are in your weight-loss timeline before replacing everything you own